QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector, is capturing investor attention with its diagnostic testing solutions. As a key contender in the medical devices industry, QuidelOrtho’s performance metrics and analyst projections reveal a compelling narrative for potential investors.

**Current Market Position**

With a market capitalization of $1.44 billion, QuidelOrtho is firmly established in the United States. Currently trading at $21.19, the stock has experienced a slight dip of 0.06%, yet its 52-week range of $19.73 to $41.96 suggests significant volatility and opportunity. Investors should note the potential upside of 63.60% based on the average target price of $34.67, as projected by…